Status: Recruiting
Cabotegravir-Hormone PK/PD Interactions for HIV Prevention
This is a research study to better understand how long-acting cabotegravir (CAB-LA) works to prevent HIV in people. This study will also evaluate the impact of endogenous and therapeutic hormones on CAB-LA pharmacology. The investigators will also evaluate if participants experience any medical problems when taking CAB-LA.
Participants needed: 32
Trial details
Phase: Phase 1Age: 19+Biological sex: AllType: InterventionalSponsor: Johns Hopkins UniversityUpdated: Jul 13, 2026Locations: 1
Eligibility criteria
19 years of age or older [+14]
History of previous long-acting antiretroviral use, including CAB-LA and long-ac... [+21]